KRAS-mutated plasma DNA as predictor of outcome from irinotecan monotherapy in metastatic colorectal cancer

BACKGROUND: We investigated the clinical implications of KRAS and BRAF mutations detected in both archival tumor tissue and plasma cell-free DNA in metastatic colorectal cancer patients treated with irinotecan monotherapy. METHODS: Two hundred and eleven patients receiving second-line irinotecan (35...

Descripción completa

Detalles Bibliográficos
Autores principales: Spindler, K G, Appelt, A L, Pallisgaard, N, Andersen, R F, Jakobsen, A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3859936/
https://www.ncbi.nlm.nih.gov/pubmed/24263065
http://dx.doi.org/10.1038/bjc.2013.633

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3859936/
https://www.ncbi.nlm.nih.gov/pubmed/24263065
http://dx.doi.org/10.1038/bjc.2013.633

Ejemplares similares